180 related articles for article (PubMed ID: 24180516)
1. Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer.
Chen DL; Wang ZQ; Ren C; Zeng ZL; Wang DS; Luo HY; Wang F; Qiu MZ; Bai L; Zhang DS; Wang FH; Li YH; Xu RH
J Transl Med; 2013 Nov; 11():277. PubMed ID: 24180516
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.
Chen DL; Wang DS; Wu WJ; Zeng ZL; Luo HY; Qiu MZ; Ren C; Zhang DS; Wang ZQ; Wang FH; Li YH; Kang TB; Xu RH
Carcinogenesis; 2013 Apr; 34(4):803-11. PubMed ID: 23275153
[TBL] [Abstract][Full Text] [Related]
3. Expression of paxillin in laryngeal squamous cell carcinoma and its prognostic value.
Li L; Wang J; Gao L; Gong L
Int J Clin Exp Pathol; 2015; 8(8):9232-9. PubMed ID: 26464671
[TBL] [Abstract][Full Text] [Related]
4. Paxillin is positively correlated with the clinicopathological factors of colorectal cancer, and knockdown of Paxillin improves sensitivity to cetuximab in colorectal cancer cells.
Du C; Wang X; Zhang J; Liu X; Zhu J; Liu Y
Oncol Rep; 2016 Jan; 35(1):409-17. PubMed ID: 26530439
[TBL] [Abstract][Full Text] [Related]
5. Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway.
Wen L; Zhang X; Zhang J; Chen S; Ma Y; Hu J; Yue T; Wang J; Zhu J; Wu T; Wang X
Oncol Rep; 2020 Sep; 44(3):1105-1115. PubMed ID: 32705241
[TBL] [Abstract][Full Text] [Related]
6. Promotive effect of Talin-1 protein on gastric cancer progression through PTK2-PXN-VCL-E-Cadherin-CAPN2-MAPK1 signaling axis.
Yan H; Guo M; Zou J; Xiao F; Yi L; He Y; He B
J Clin Lab Anal; 2020 Dec; 34(12):e23555. PubMed ID: 32951272
[TBL] [Abstract][Full Text] [Related]
7. Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting.
Wu DW; Chuang CY; Lin WL; Sung WW; Cheng YW; Lee H
Carcinogenesis; 2014 Aug; 35(8):1823-9. PubMed ID: 24894864
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma.
Sun LH; Yang FQ; Zhang CB; Wu YP; Liang JS; Jin S; Wang Z; Wang HJ; Bao ZS; Yang ZX; Jiang T
CNS Neurosci Ther; 2017 Jan; 23(1):69-75. PubMed ID: 27637748
[TBL] [Abstract][Full Text] [Related]
9. L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer.
Chen DL; Zeng ZL; Yang J; Ren C; Wang DS; Wu WJ; Xu RH
J Hematol Oncol; 2013 Jun; 6():43. PubMed ID: 23806079
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.
Ito T; Yamada S; Tanaka C; Ito S; Murai T; Kobayashi D; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
Ann Surg Oncol; 2014 Feb; 21(2):560-8. PubMed ID: 24046108
[TBL] [Abstract][Full Text] [Related]
11. Effect of Paxillin Expression and Phosphorylation on Colorectal Cancer Prognosis and Metastasis.
Zheng H; Tsunedomi R; Xu M; Zhang Y; Kishi H; Kobayashi S; Tomochika S; Nakajima M; Matsui H; Tokumitsu Y; Shindo Y; Iida M; Ioka T; Nagano H
Anticancer Res; 2024 Feb; 44(2):511-520. PubMed ID: 38307570
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of GPR34 expression affects the progression and prognosis of human gastric adenocarcinoma by PI3K/PDK1/AKT pathway.
Yu W; Ma S; Wang L; Zuo B; Li M; Qiao Z; Pan X; Liu Y; Wang J
Histol Histopathol; 2013 Dec; 28(12):1629-38. PubMed ID: 23836308
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-212 functions as an epigenetic-silenced tumor suppressor involving in tumor metastasis and invasion of gastric cancer through down-regulating PXN expression.
Li D; Li Z; Xiong J; Gong B; Zhang G; Cao C; Jie Z; Liu Y; Cao Y; Yan Y; Xiong H; Qiu L; Yang M; Chen H; Jiang S; Yang X; Chen H
Am J Cancer Res; 2015; 5(10):2980-97. PubMed ID: 26693054
[TBL] [Abstract][Full Text] [Related]
15. Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer.
Cheng HC; Liu YP; Shan YS; Huang CY; Lin FC; Lin LC; Lee L; Tsai CH; Hsiao M; Lu PJ
Carcinogenesis; 2013 Nov; 34(11):2452-9. PubMed ID: 23774402
[TBL] [Abstract][Full Text] [Related]
16. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
17. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
[TBL] [Abstract][Full Text] [Related]
18. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting.
Wu DW; Cheng YW; Wang J; Chen CY; Lee H
Cancer Res; 2010 Dec; 70(24):10392-401. PubMed ID: 21159652
[TBL] [Abstract][Full Text] [Related]
19. The overexpression of PXN promotes tumor progression and leads to radioresistance in cervical cancer.
Liu Q; Wang J; Tang M; Chen L; Qi X; Li J; Yu J; Qiu H; Wang Y
Future Oncol; 2018 Feb; 14(3):241-253. PubMed ID: 29318915
[TBL] [Abstract][Full Text] [Related]
20. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
